CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 78 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $0 | – | 11 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 11 | -100.0% | 0.00% | -100.0% |
Q3 2017 | $3,619,000 | +442.6% | 245,337 | +413.6% | 0.00% | +300.0% |
Q2 2017 | $667,000 | +16.2% | 47,772 | -6.5% | 0.00% | 0.0% |
Q2 2016 | $574,000 | -16.7% | 51,109 | +1.4% | 0.00% | 0.0% |
Q1 2016 | $689,000 | +40.3% | 50,401 | +95.0% | 0.00% | 0.0% |
Q4 2015 | $491,000 | +1536.7% | 25,853 | +1192.6% | 0.00% | – |
Q2 2015 | $30,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2015 | $30,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |